Remission Medical
PrivateLast Round
Series A
Apr 9, 2026
Total Funding Raised
$6.2M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Remission Medical operates in Healthcare & Life Sciences and is based in Virginia. Its latest recorded funding round was a Series A round in April 2026.
Remission Medical is a healthcare company that provides a virtual rheumatology platform to expand access to care by partnering with health systems and specialty practices.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, EHR & EMR, Vertical SaaS
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Remission Medical Comparables
Compare Remission Medical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sevaro Health | 82% | |
| AmplifyMD | 82% | |
| KeyCare | 78% |
For institutional investors. Book with your work email.
Remission Medical Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Remission Medical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Blue Heron Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 178% MoM, reaching 4.3K.
- Jul 19, 2026
Grew 20% QoQ, from 25 to 30 employees.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- hiresOct 5, 2026
Remission Medical, Inc. announces that Rick Diaz, MBA, joins its Advisory Consultant Program as an Advisory Member in Virginia on Oct 5th '26, providing strategic counsel on healthcare operations, value-based care, payer strategy and financial performance.
- hiresOct 1, 2026
Remission Medical, Inc. announced in Virginia on Oct 1st '26 that Kelleny Berchuck, PhD, joined its Advisory Consultant Program as a Strategic Advisor to provide counsel on healthcare innovation, enterprise strategy and scalable business models.
- hiresSep 16, 2026
Remission Medical, Inc. announces that Jonathan M. Gerber, MD, joins its Advisory Consultant Program as a Senior Advisor in Virginia on Sep 14th '26, bringing expertise in clinical innovation, translational research, and emerging cellular therapies.
- hiresSep 16, 2026
Remission Medical, Inc. appoints Jonathan M. Gerber, MD, as a Senior Advisor in its Advisory Consultant Program in Virginia on Sep 14th '26, adding his clinical innovation, translational research, and healthcare leadership expertise as the company expands partnerships with health systems and specialty practices.
- hiresSep 10, 2026
Remission Medical, Inc. announces that Richard J. Mata, MD, MS, joins its Advisory Consultant Program as a Senior Advisor in Virginia on Sep 10th '26, bringing expertise in clinical medicine, medical informatics, healthcare technology and enterprise systems.
For institutional investors. Book with your work email.
Remission Medical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Remission Medical's valuation, stock price, and market status.
Is Remission Medical a public or private company?
Remission Medical is a private company.
What is the current stock price of Remission Medical?
Remission Medical is a private company, so its shares have no public market price. Caplight tracks Remission Medical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Remission Medical worth (valuation)?
Valuation information for Remission Medical is not publicly available.
Can I buy Remission Medical stock?
Remission Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Remission Medical's last funding round?
Remission Medical's most recent funding round was Series A on April 9, 2026.
Who are the main investors in Remission Medical?
Key investors in Remission Medical include Blue Heron Capital.
Will Remission Medical IPO soon?
No public IPO plans have been announced for Remission Medical.
How can I track Remission Medical secondary market activity?
Caplight tracks bids, offers, and trades in Remission Medical's shares on secondary markets.